A Multiplex Network Control Method for Identifying Personalized Cancer Driver Genes

被引:0
作者
Zhang, Tong [1 ,2 ]
Zhang, Shao-Wu [1 ]
Li, Yan [1 ]
Xie, Ming-Yu [1 ]
机构
[1] Northwestern Polytech Univ, Minist Educ, Sch Automat, Key Lab Informat Fus Technol, Xian 710072, Peoples R China
[2] Pingdingshan Univ, Sch Elect & Mech Engn, Pingdingshan 467000, Peoples R China
基金
中国国家自然科学基金;
关键词
multiplex biomolecular networks; multiplex network control; personalized cancer driver genes; sample-specific multiplex network; minimum vertex cover set; SOMATIC MUTATIONS; GENOME; PATHWAYS;
D O I
10.16476/j.pibb.2023.0392
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective Inferring cancer driver genes, especially rare or sample-specific cancer driver genes, is crucial for precision oncology. Considering the high inter-tumor heterogeneity, a few recent methods attempt to reveal cancer driver genes at the individual level. However, most of these methods generally integrate multi-omics data into a single biomolecular network (e.g., gene regulatory network or protein-protein interaction network) to identify cancer driver genes, which results in missing important interactions highlighted in different networks. Thus, the development of a multiplex network method is imperative in order to integrate the interactions of different biomolecular networks and facilitate the identification of cancer driver genes.Methods A multiplex network control method called Personalized cancer Driver Genes with Multiplex biomolecular Networks (PDGMN) was proposed. Firstly, the sample-specific multiplex network, which contains protein-protein interaction layer and gene-gene association layer, was constructed based on gene expression data. Subsequently, somatic mutation data was integrated to weight the nodes in the sample-specific multiplex network. Finally, a weighted minimum vertex cover set identification algorithm was designed to find the optimal set of driver nodes, facilitating the identification of personalized cancer driver genes.Results The results derived from three TCGA cancer datasets indicate that PDGMN outperforms other existing methods in identifying personalized cancer driver genes, and it can effectively identify the rare driver genes in individual patients. Particularly, the experimental results indicate that PDGMN can capture the unique characteristics of different biomolecular networks to improve cancer driver gene identification.Conclusion PDGMN can effectively identify personalized cancer driver genes and broaden our understanding of cancer driver gene identification from a multiplex network perspective. The source code and datasets used in this work are available at https://github.com/NWPU-903PR/PDGMN.
引用
收藏
页码:1711 / 1726
页数:16
相关论文
共 60 条
  • [41] pDriver: a novel method for unravelling personalized coding and miRNA cancer drivers
    Pham, Vu V. H.
    Liu, Lin
    Bracken, Cameron P.
    Nguyen, Thin
    Goodall, Gregory J.
    Li, Jiuyong
    Le, Thuc D.
    [J]. BIOINFORMATICS, 2021, 37 (19) : 3285 - 3292
  • [42] CBNA: A control theory based method for identifying coding and non-coding cancer drivers
    Pham, Vu V. H.
    Liu, Lin
    Bracken, Cameron P.
    Goodall, Gregory J.
    Long, Qi
    Li, Jiuyong
    Le, Thuc D.
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (12)
  • [43] The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens
    Repana, Dimitra
    Nulsen, Joel
    Dressler, Lisa
    Bortolomeazzi, Michele
    Venkata, Santhilata Kuppili
    Tourna, Aikaterini
    Yakovleva, Anna
    Palmieri, Tommaso
    Ciccarelli, Francesca D.
    [J]. GENOME BIOLOGY, 2019, 20 (1)
  • [44] HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology
    Shrestha, Raunak
    Hodzic, Ermin
    Sauerwald, Thomas
    Dao, Phuong
    Wang, Kendric
    Yeung, Jake
    Anderson, Shawn
    Vandin, Fabio
    Haffari, Gholamreza
    Collins, Colin C.
    Sahinalp, S. Cenk
    [J]. GENOME RESEARCH, 2017, 27 (09) : 1573 - 1588
  • [45] The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
    Sondka, Zbyslaw
    Bamford, Sally
    Cole, Charlotte G.
    Ward, Sari A.
    Dunham, Ian
    Forbes, Simon A.
    [J]. NATURE REVIEWS CANCER, 2018, 18 (11) : 696 - 705
  • [46] Journeys into the genome of cancer cells
    Stratton, Michael R.
    [J]. EMBO MOLECULAR MEDICINE, 2013, 5 (02) : 169 - 172
  • [47] Exploring the Genomes of Cancer Cells: Progress and Promise
    Stratton, Michael R.
    [J]. SCIENCE, 2011, 331 (6024) : 1553 - 1558
  • [48] The cancer genome
    Stratton, Michael R.
    Campbell, Peter J.
    Futreal, P. Andrew
    [J]. NATURE, 2009, 458 (7239) : 719 - 724
  • [49] Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI [10.1093/nar/gky1131, 10.1093/nar/gkac1000]
  • [50] OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes
    Tamborero, David
    Gonzalez-Perez, Abel
    Lopez-Bigas, Nuria
    [J]. BIOINFORMATICS, 2013, 29 (18) : 2238 - 2244